Skip to main content
. 2023 Nov 14;16(2):e13498. doi: 10.1111/1753-0407.13498

TABLE 3.

Comparison of early‐onset T2DM patients with different insulin resistance degree.

Variables Mild IR group Moderate IR group Severe IR group P value
Gender (%) .793
Male 258 (76.8) 130 (76.5) 80 (80.0)
Female 78 (23.2) 40 (23.5) 20 (20.0)
Onset age (year) 31.36 ± 0.32 31.54 ± 0.45 31.39 ± 0.58 .884
SBP (mm Hg) 124.36 ± 0.83 129.70 ± 1.26 131.58 ± 1.68 <.0001
DBP (mm Hg) 79.43 ± 0.63 84.03 ± 1.02 84.62 ± 1.21 <.0001
BMI (kg/m2) 26.30 ± 0.25 29.18 ± 0.42 30.94 ± 0.56 <.0001
Weight (kg) 77.16 ± 0.87 86.21 ± 1.42 91.47 ± 2.00 <.0001
Height (cm) 170.95 ± 0.46 171.58 ± 0.62 171.36 ± 0.72 .627
Smoking status (%) .335
No 166 (49.4) 95 (55.9) 55 (55.0)
Yes 170 (50.6) 75 (44.1) 45 (45.0)
Drink (%) .466
No 198 (58.9) 104 (61.2) 54 (54.0)
Yes 138 (41.1) 66 (38.8) 46 (46.0)
DM family history (%) .093
No 166 (49.4) 72 (42.4) 38 (38.0)
Yes 170 (51.7) 98 (57.6) 62 (62.0)
FBG (mmol/L) 9.24 ± 0.22 10.41 ± 0.33 10.81 ± 0.49 <.0001
HbA1c (%) 9.69 ± 0.16 9.65 ± 0.17 9.74 ± 0.23 .996
Fatty liver (%) <.0001
No 126 (37.5) 19 (11.2) 11 (11.0)
Yes 210 (62.5) 151 (88.8) 89 (89.0)
Diabetic retinopathy (%) .790
No 317 (94.3) 160 (94.1) 96 (96.0)
Yes 19 (5.7) 10 (5.9) 4 (4.0)
DPN (%) .993
No 319 (94.9) 161 (94.7) 94 (94.0)
Yes 17 (5.1) 9 (5.3) 6 (6.0)
Macrovascular diseases (%) .563
No 267 (79.5) 128 (75.3) 78 (78.0)
Yes 69 (20.5) 42 (24.7) 22 (22.0)
Diabetic nephropathy (%) .016
No 321 (95.5) 155 (91.2) 88 (88.9)
Yes 15 (4.5) 15 (8.8) 12 (12.1)
WHR 0.95 ± 0.004 0.98 ± 0.005 0.99 ± 0.006 <.0001
eGFR (ml/min/1.73 m2) 122.98 ± 1.80 118.17 ± 1.99 115.26 ± 2.58 .046
UA (umol/L) 348.26 ± 11.34 375.26 ± 8.84 437.30 ± 32.54 .001
TG (mmol/L) 2.56 ± 0.18 3.56 ± 0.25 4.17 ± 0.11 <.0001
TC (mmol/L) 4.76 ± 0.11 5.01 ± 0.11 5.20 ± 0.22 .063
HDL‐C (mmol/L) 0.97 ± 0.02 0.90 ± 0.02 0.85 ± 0.05 .02
LDL‐C (mmol/L) 2.88 ± 0.05 2.97 ± 0.08 3.00 ± 0.11 .496
ALT (U/L) 24.30 (14.45,41.10) 37.50 (23.00,61.20) 54.25 (28.38,95.70) <.0001
AST (U/L) 16.80 (12.75,25.95) 22.20 (16.00,32.80) 28.85 (18.45,48.70) <.0001
GGT (U/L) 44.34 ± 4.30 52.99 ± 3.56 72.22 ± 6.82 .001
WBC (109/L) 6.81 ± 0.10 7.23 ± 0.13 7.45 ± 0.22 .003
Neutrophil (%) 0.54 ± 0.005 0.55 ± 0.007 0.54 ± 0.009 .901
NLR 1.67 ± 0.05 1.71 ± 0.07 1.69 ± 0.09 .970
Lymphocyte (%) 0.36 ± 0.005 0.36 ± 0.006 0.36 ± 0.009 .765
Monocyte (%) 0.06 ± 0.001 0.07 ± 0.001 0.07 ± 0.002 .920
MLR 0.19 ± 0.005 0.19 ± 0.006 0.19 ± 0.009 .983
Platelet (109/L) 248.38 ± 3.8 247.47 ± 5.18 259.45 ± 7.61 .346
PHR 280.53 ± 5.98 294.36 ± 9.05 322.50 ± 13.08 .005
RC (mmol/L) 0.52 (0.33,0.84) 0.78 (0.48,1.23) 0.78 (0.52,1.67) <.0001
LDL‐C/HDL‐C 3.23 ± 0.07 3.46 ± 0.09 3.59 ± 0.13 .02
TG/HDL‐C 1.93 (1.13,3.02) 2.81 (1.82,4.87) 2.84 (1.99,7.04) <.0001
TC/HDL‐C 5.36 ± 0.15 6.00 ± 0.19 6.59 ± 0.36 <.0001
UACR 8.80 (5.30,15.00) 9.00 (5.00,18.30) 11.00 (6.33,25.75) .075

Abbreviations: ALT, alanine aminotransferase; AST, aspartic transaminase; BMI, body mass index; DBP, diastolic blood pressure; DM, diabetes mellitus; DPN, diabetic peripheral neuropathy; eGFR, estimated glomerular filtration rate; FBG, fasting blood‐glucose; GGT, gamma‐glutamyl transpeptidase; HbA1c, glycosylated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; IR, insulin resistance; LDL‐C, low‐density lipoprotein cholesterol; LDL‐C/HDL‐C, LDL‐C/HDL‐C ratio; MLR, monocyte to lymphocyte ratio; NLR, neutrophil to lymphocyte ratio; PHR, platelet/HDL‐C ratio; RC, remnant cholesterol; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus; TC, total cholesterol; TC/HDL‐C, TC/HDL‐C ratio; TG, triglyceride; TG/HDL‐C, TG/HDL‐C ratio; UA, uric acid; UACR, urinary albumin‐to‐creatinine ratio; WBC, white blood cell; WHR, waist‐to‐hip ratio.